Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
3,490,534
-
Share change
-
+915,483
-
Total reported value
-
$15,080,277
-
Put/Call ratio
-
1.2%
-
Price per share
-
$4.32
-
Number of holders
-
30
-
Value change
-
+$4,150,477
-
Number of buys
-
14
-
Number of sells
-
8
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q2 2023
As of 30 Jun 2023,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,490,534 shares.
The largest 10 holders included
COOPERMAN LEON G, VANGUARD GROUP INC, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, Bleichroeder LP, EAM Investors, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, GEODE CAPITAL MANAGEMENT, LLC, FIRST MANHATTAN CO. LLC., NORTHERN TRUST CORP, and BlackRock Inc..
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.